MeVis Medical Solutions (0HI7) Stock Statistics & Valuation Metrics
Total Valuation
MeVis Medical Solutions has a market cap or net worth of EUR 37.13M. The enterprise value is EUR 39.30T.
- Market Cap
- EUR 37.13M
- Enterprise Value
- EUR 39.30T
Share Statistics
MeVis Medical Solutions has 1,820,000 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 1,820,000
- Owned by Insiders
- ―
- Owned by Institutions
- ―
Financial Efficiency
MeVis Medical Solutions’s return on equity (ROE) is 0.18 and return on invested capital (ROIC) is 11.16%.
- Return on Equity (ROE)
- 0.18
- Return on Assets (ROA)
- 0.12
- Return on Invested Capital (ROIC)
- 11.16%
- Return on Capital Employed (ROCE)
- 0.12
- Revenue Per Employee
- 126.46K
- Profits Per Employee
- 24.93K
- Employee Count
- 127
- Asset Turnover
- 0.62
- Inventory Turnover
- 0.00
Valuation Ratios
The current PE Ratio of MeVis Medical Solutions is 26.84. MeVis Medical Solutions’s PEG ratio is -0.40.
- PE Ratio
- 26.84
- PS Ratio
- 2.40
- PB Ratio
- 2.08
- Price to FCF
- 0.00
- Price to Operating Cash Flow
- 0.00
- PEG Ratio
- -0.40
Income Statement
In the last 12 months, MeVis Medical Solutions had revenue of 16.06M and earned 3.17M in profits. Earnings per share was 1.74.
- Revenue
- 16.06M
- Gross Profit
- 15.69M
- Operating Income
- 2.34M
- Pretax Income
- 3.28M
- Net Income
- 3.17M
- EBITDA
- 3.43M
- Earnings Per Share (EPS)
- 1.74
Cash Flow
In the last 12 months, operating cash flow was 0 and capital expenditures 0, giving a free cash flow of 0 billion.
- Operating Cash Flow
- 0
- Free Cash Flow
- 0
- Free Cash Flow per Share
- 0.00
Dividends & Yields
MeVis Medical Solutions pays an annual dividend of ―, resulting in a dividend yield of 4.68%
- Dividend Per Share
- ―
- Dividend Yield
- 4.68%
- Payout Ratio
- N/A
- Free Cash Flow Yield
- 0.00%
- Earnings Yield
- 3.73%
Stock Price Statistics
- Beta
- -0.06
- 52-Week Price Change
- -9.84%
- 50-Day Moving Average
- 22.89
- 200-Day Moving Average
- 23.30
- Relative Strength Index (RSI)
- 30.59
- Average Volume (3m)
- 1
Important Dates
MeVis Medical Solutions upcoming earnings date is Jan 28, 2027, TBA (Not Confirmed).
- Last Earnings Date
- May 21, 2026
- Next Earnings Date
- Jan 28, 2027
- Ex-Dividend Date
- ―
Financial Position
MeVis Medical Solutions as a current ratio of 1.58, with Debt / Equity ratio of 0.00%
- Current Ratio
- 1.58
- Quick Ratio
- 1.58
- Debt to Market Cap
- 0.00
- Net Debt to EBITDA
- -1.90
- Interest Coverage Ratio
- 4058.20
Taxes
In the past 12 months, MeVis Medical Solutions has paid 113.00K in taxes.
- Income Tax
- 113.00K
- Effective Tax Rate
- 0.03
Enterprise Valuation
MeVis Medical Solutions EV to EBITDA ratio is 42.32, with an EV/FCF ratio of 0.00.
- EV to Sales
- 2.16
- EV to EBITDA
- 42.32
- EV to Free Cash Flow
- 0.00
- EV to Operating Cash Flow
- 0.00
Balance Sheet
MeVis Medical Solutions has EUR 3.65M in cash and marketable securities with EUR 0.00 in debt, giving a net cash position of EUR 3.65M billion.
- Cash & Marketable Securities
- EUR 3.65M
- Total Debt
- EUR 0.00
- Net Cash
- EUR 3.65M
- Net Cash Per Share
- EUR 2.01
- Tangible Book Value Per Share
- EUR 9.79
Margins
Gross margin is 20.24%, with operating margin of 16.36%, and net profit margin of 8.94%.
- Gross Margin
- 20.24%
- Operating Margin
- 16.36%
- Pretax Margin
- 9.56%
- Net Profit Margin
- 8.94%
- EBITDA Margin
- 5.11%
- EBIT Margin
- 4.18%
Analyst Forecast
The average price target for MeVis Medical Solutions is ―, which is 11.43% higher than the current price. The consensus rating is ―
- Price Target
- ―
- Price Target Upside
- ―
- Analyst Consensus
- ―
- Analyst Count
- ―
- Revenue Growth Forecast
- -6.92%
- EPS Growth Forecast
- -67.82%
Scores
- Smart Score
- 4
- AI Score
- ―
